S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
NASDAQ:BDRX

Biodexa Pharmaceuticals (BDRX) Stock Price, News & Analysis

$2.68
+0.05 (+1.90%)
(As of 12/29/2023 ET)
Today's Range
$2.52
$2.75
50-Day Range
$2.33
$5.11
52-Week Range
$2.05
$361.60
Volume
58,246 shs
Average Volume
82,909 shs
Market Capitalization
$3.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BDRX stock logo

About Biodexa Pharmaceuticals Stock (NASDAQ:BDRX)

Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the bio-delivery and biodistribution of medicines in Belgium and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTX223, a long-acting injectable formulations of biologic products, such as mAbs or other high molecular weight proteins. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

BDRX Stock Price History

BDRX Stock News Headlines

Biodexa Pharmaceuticals Plc (BDRX)
New Year's Sale: Get MarketBeat All Access Free For 30 Days
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscription
New Year's Sale: Get MarketBeat All Access Free For 30 Days
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscription
Results of Appeal of Delisting Determination
Biodexa Pharmaceuticals PLC: ADR Ratio Change
ADR Ratio Change
Appeal of Delisting Determination
See More Headlines
Receive BDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/31/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BDRX
Fax
N/A
Employees
27
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$870,000.00
Book Value
$57.76 per share

Miscellaneous

Free Float
1,283,000
Market Cap
$3.46 million
Optionable
Not Optionable
Beta
1.95
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Stephen A. Stamp (Age 61)
    CEO, CFO, Company Sec. & Director
    Comp: $289.04k
  • Dr. Dmitry Zamoryakhin M.D. (Age 43)
    Chief Scientific Officer
    Comp: $287.56k
  • Dr. Daniel Palmer MBA
    Ph.D., VP of Technology
  • Ms. Fiona Sharp
    Group Financial Controller














BDRX Stock Analysis - Frequently Asked Questions

How have BDRX shares performed in 2023?

Biodexa Pharmaceuticals' stock was trading at $33.7360 at the beginning of 2023. Since then, BDRX stock has decreased by 92.1% and is now trading at $2.68.
View the best growth stocks for 2023 here
.

When did Biodexa Pharmaceuticals' stock split?

Shares of Biodexa Pharmaceuticals reverse split on the morning of Wednesday, July 5th 2023. The 1-80 reverse split was announced on Wednesday, July 5th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 5th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

How do I buy shares of Biodexa Pharmaceuticals?

Shares of BDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BDRX) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -